A detailed history of Jim Simons (Renaissance Technologies LLC) transactions in Omega Therapeutics, Inc. stock. As of the latest transaction made, Renaissance Technologies LLC holds 474,600 shares of OMGA stock, worth $398,664. This represents 0.0% of its overall portfolio holdings.

Number of Shares
474,600
Previous 128,400 269.63%
Holding current value
$398,664
Previous $265,000 118.49%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$1.22 - $2.25 $422,364 - $778,950
346,200 Added 269.63%
474,600 $579,000
Q2 2024

Aug 09, 2024

BUY
$1.86 - $3.2 $238,824 - $410,880
128,400 New
128,400 $265,000
Q4 2023

Feb 13, 2024

BUY
$1.35 - $3.21 $27,540 - $65,484
20,400 New
20,400 $61,000
Q2 2022

Aug 12, 2022

BUY
$2.01 - $7.19 $192,282 - $687,816
95,663 New
95,663 $364,000

Others Institutions Holding OMGA

About Omega Therapeutics, Inc.


  • Ticker OMGA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 47,853,400
  • Market Cap $40.2M
  • Description
  • Omega Therapeutics, Inc. operates as a development-stage biopharmaceutical company. Its OMEGA Epigenomic Programming platform is designed to coopt nature's operating system by harnessing the power of epigenetics, the mechanism for gene control and cell differentiation. The company is developing omega epigenomic controller (OEC) candidates to up-...
More about OMGA
Track Jim Simons's Portfolio

Track Jim Simons Portfolio

Follow Jim Simons (Renaissance Technologies LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

News

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.